About Applied Microarrays
Foundations & Business Model
Applied Microarrays (“AMI”) was founded in 2006 by CEO Alastair Malcolm, with the business model of manufacturing Point-of-Care and High Throughput DNA and protein arrays whose custom bio-content is developed by AMI’s customers.
AMI acquired the microarray assets of GE Healthcare in 2007, and hired their key talent who had developed arrays for whole genome expression arrays, SNP ‘s, microRNA’s and immunoassays. The array manufacturing equipment from GE has unique features enabling quality, accuracy and repeatability not available in tools sold on the general market.
In October 2021 AMI was acquired by SCHOTT MINIFAB, a world leading microfluidic diagnostics and lifescience company. AMI now forms the headquarters of SCHOTT MINIFAB’s North American operations. Combined, AMI and SCHOTT MINIFAB have a team of over 300 specialists with manufacturing sites in Europe, Australia and USA.
The merging of AMI and SCHOTT MINIFAB capabilities enables this new world-wide team to better meet growing market demands for the development and manufacture of more advanced and complex products.
Quality Philosophy & Systems
AMI’s entire team has been trained in Six Sigma characterization and control techniques, and applies those tools in driving optimum performance and repeatable manufacturing of our customers’ products.
AMI’s approach is that more regulations will be implemented going forward to multiplex diagnostic devices. Accordingly we treat our customer engagements with quality systems that will enable their products to be accepted successfully in regulated markets.
AMI’s Quality Policy is very simple and focused, directed towards “Three C”’s:
- Continuous Improvement
ISO 9001 and 13485
AMI adapted GE’s quality systems to the new business model, and has operated continuously under ISO 9001 and 13485.
Certificates, available for download: ISO 9001 – 13485 Certification
AMI’s headquarter is in Tempe, Arizona, in a semiconductor and flat panel display cleanroom originally constructed and operated by Motorola. The central services for clean air, water, gases, waste disposal and environmental controls are world-class and a key contributor to our consistent manufacturing.
AMI is part of SCHOTT MINIFAB, a contract developer and manufacturer of microfluidic devices and other consumables for diagnostics and lifescience research. SCHOTT MINIFAB have completed over 1000 projects worldwide and have earned a well-established track record of success. AMI has been working for many years with SCHOTT MINIFAB’s NEXTERION® range of coated and cleaned glass substrates as a basis for microarray manufacturing.
Being part of SCHOTT MINIFAB gives clients access to world-leading technology and global expertise across microfluidics, bioscience, polymer micro-fabrication and glass manufacturing in an ISO 9001 and 13485 context. In addition, as part of SCHOTT AG, clients now benefit from the backing of an over 130-year-old company with 16,000+ employees and more than €2 Billion in annual revenue.